BRST5:Table of Contents

Epithelial tumours of the breast (Overview Page Link)

Benign epithelial proliferations and precursors
  - BRST5:Usual ductal hyperplasia
  - BRST5:Columnar cell lesions, including flat epithelial atypia
  - BRST5:Atypical ductal hyperplasia

Adenosis and benign sclerosing lesions
  - BRST5:Sclerosing adenosis
  - BRST5:Apocrine adenosis and adenoma
  - BRST5:Microglandular adenosis
  - BRST5:Radial scar / complex sclerosing lesion

Adenomas
  - BRST5:Tubular adenoma
  - BRST5:Lactating adenoma
  - BRST5:Ductal adenoma

Epithelial-myoepithelial tumours
  - BRST5:Pleomorphic adenoma
  - BRST5:Adenomyoepithelioma
  - BRST5:Malignant adenomyoepithelioma

Papillary neoplasms
  - BRST5:Intraductal papilloma
  - BRST5:Papillary ductal carcinoma in situ
  - BRST5:Encapsulated papillary carcinoma
  - BRST5:Solid papillary carcinoma (in situ and invasive)
  - BRST5:Invasive papillary carcinoma

Non-invasive lobular neoplasia
  - BRST5:Atypical lobular hyperplasia
  - BRST5:Lobular carcinoma in situ

Ductal carcinoma in situ
  - BRST5:Ductal carcinoma in situ

Invasive breast carcinoma: General overview
  - BRST5:Invasive breast carcinoma of no special type
  - BRST5:Microinvasive carcinoma
  - BRST5:Invasive lobular carcinoma
  - BRST5:Tubular carcinoma
  - BRST5:Cribriform carcinoma
  - BRST5:Mucinous carcinoma
  - BRST5:Mucinous cystadenocarcinoma
  - BRST5:Invasive micropapillary carcinoma
  - BRST5:Carcinoma with apocrine differentiation
  - BRST5:Metaplastic carcinoma

Rare and salivary gland-type tumours
  - BRST5:Acinic cell carcinoma
  - BRST5:Adenoid cystic carcinoma
  - BRST5:Secretory carcinoma
  - BRST5:Mucoepidermoid carcinoma
  - BRST5:Polymorphous adenocarcinoma
  - BRST5:Tall cell carcinoma with reversed polarity

Neuroendocrine neoplasms
  - BRST5:Neuroendocrine tumour
  - BRST5:Neuroendocrine carcinoma

Fibroepithelial tumours and hamartomas of the breast (Overview Page Link)

Fibroepithelial tumours and hamartomas of the breast
  - BRST5:Hamartoma
  - BRST5:Fibroadenoma
  - BRST5:Phyllodes tumour

Tumours of the nipple (Overview Page Link)

Tumours of the nipple

Epithelial tumours
  - BRST5:Syringomatous tumour
  - BRST5:Nipple adenoma
  - BRST5:Paget disease of the breast

Mesenchymal tumours of the breast (Overview Page Link)

Mesenchymal tumours of the breast

Vascular tumours
  - BRST5:Haemangioma
  - BRST5:Angiomatosis
  - BRST5:Atypical vascular lesions
  - BRST5:Postradiation angiosarcoma of the breast
  - BRST5:Primary angiosarcoma of the breast

Fibroblastic and myofibroblastic tumours 
  - BRST5:Nodular fasciitis
  - BRST5:Myofibroblastoma
  - BRST5:Desmoid fibromatosis
  - BRST5:Inflammatory myofibroblastic tumour

Peripheral nerve sheath tumours
  - BRST5:Schwannoma
  - BRST5:Neurofibroma
  - BRST5:Granular cell tumour

Smooth muscle tumours
  - BRST5:Leiomyoma
  - BRST5:Leiomyosarcoma

Adipocytic tumours
  - BRST5:Lipoma
  - BRST5:Angiolipoma
  - BRST5:Liposarcoma

Other mesenchymal tumours and tumour-like conditions
  - BRST5:Pseudoangiomatous stromal hyperplasia

Haematolymphoid tumours of the breast (Overview Page Link)

Haematolymphoid tumours of the breast

Lymphoma
  - BRST5:Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma)
  - BRST5:Follicular lymphoma
  - BRST5:Diffuse large B-cell lymphoma
  - BRST5:Burkitt lymphoma
  - BRST5:Breast implant-associated anaplastic large cell lymphoma

Tumours of the male breast (Overview Page Link)

Epithelial tumours
  - BRST5:Gynaecomastia
  - BRST5:Carcinoma in situ
  - BRST5:Invasive carcinoma
  - BRST5:Metastases to the breast

Genetic tumour syndromes of the breast (Overview Page Link)

Syndromes
  - BRST5:BRCA1/2-associated hereditary breast and ovarian cancer syndrome
  - BRST5:Cowden syndrome
  - BRST5:Ataxia-telangiectasia
  - BRST5:Li-Fraumeni syndrome, TP53-associated
  - BRST5:Li-Fraumeni syndrome, CHEK2-associated
  - BRST5:CDH1-associated breast cancer
  - BRST5:PALB2-associated cancers
  - BRST5:Peutz-Jeghers syndrome
  - BRST5:Neurofibromatosis type 1
  - BRST5:The polygenic component of breast cancer susceptibility